These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23090506)

  • 21. Delivery vehicles for small interfering RNA in vivo.
    de Fougerolles AR
    Hum Gene Ther; 2008 Feb; 19(2):125-32. PubMed ID: 18257677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
    Li T; Wu M; Zhu YY; Chen J; Chen L
    Nucleic Acid Ther; 2014 Aug; 24(4):302-12. PubMed ID: 24796432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise.
    Das M; Musetti S; Huang L
    Nucleic Acid Ther; 2019 Apr; 29(2):61-66. PubMed ID: 30562145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases.
    Rosa J; Suzuki I; Kravicz M; Caron A; Pupo AV; Praça FG; Bentley MVLB
    Curr Pharm Des; 2018; 24(23):2644-2663. PubMed ID: 30084329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. siRNA: a potential tool for future breast cancer therapy?
    Størvold GL; Andersen TI; Perou CM; Frengen E
    Crit Rev Oncog; 2006 Jul; 12(1-2):127-50. PubMed ID: 17078209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic applications of RNAi for silencing virus replication.
    Tripp RA; Tompkins SM
    Methods Mol Biol; 2009; 555():43-61. PubMed ID: 19495687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury.
    Marinho HS; Marcelino P; Soares H; Corvo ML
    Curr Pharm Des; 2018; 24(23):2692-2700. PubMed ID: 30084326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle-siRNA: A potential strategy for rheumatoid arthritis therapy?
    Feng N; Guo F
    J Control Release; 2020 Sep; 325():380-393. PubMed ID: 32653501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
    Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
    Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA interference as a gene-specific approach for molecular medicine.
    Grünweller A; Hartmann RK
    Curr Med Chem; 2005; 12(26):3143-61. PubMed ID: 16375707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo.
    Aigner A
    Appl Microbiol Biotechnol; 2007 Aug; 76(1):9-21. PubMed ID: 17457539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular design and delivery of siRNA.
    Inoue A; Sawata SY; Taira K
    J Drug Target; 2006; 14(7):448-55. PubMed ID: 17062391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Journey of siRNA: Clinical Developments and Targeted Delivery.
    Nikam RR; Gore KR
    Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.